You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Suppliers and packagers for NICORETTE (MINT)


✉ Email this page to a colleague

« Back to Dashboard


NICORETTE (MINT)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings NICORETTE (MINT) nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0157-07 1 BLISTER PACK in 1 CARTON (0135-0157-07) / 110 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE (MINT) nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0157-10 1 BLISTER PACK in 1 CARTON (0135-0157-10) / 170 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE (MINT) nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0157-11 1 BLISTER PACK in 1 CARTON (0135-0157-11) / 200 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
Haleon Us Holdings NICORETTE (MINT) nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA Haleon US Holdings LLC 0135-0229-05 1 BLISTER PACK in 1 CARTON (0135-0229-05) / 170 GUM, CHEWING in 1 BLISTER PACK 2009-06-29
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: NICORETTE (MINT)

Last updated: August 5, 2025


Introduction

Nicorette (Mint), a widely used nicotine replacement therapy (NRT) product, plays a critical role in smoking cessation programs worldwide. As a recognized over-the-counter (OTC) medical device, Nicorette offers a strategic market with multiple supply chain avenues. Ensuring an understanding of primary suppliers involved in manufacturing, raw material procurement, and distribution is essential for stakeholders aiming to navigate this competitive sector effectively. This analysis provides a comprehensive overview of the key suppliers associated with Nicorette (Mint), emphasizing manufacturing partnerships, raw material vendors, distribution channels, and regulatory considerations.


Pharmaceutical Manufacturer and Brand Ownership

The primary manufacturer and brand owner of Nicorette (Mint) is Johnson & Johnson (J&J), operating through its pharmaceutical division. J&J's robust supply chain and extensive global manufacturing network underpin the consistent availability of Nicorette products. This company develops, manufactures, and markets Nicorette’s various formulations, including gum, lozenges, and patches.

Johnson & Johnson is responsible for overseeing the entire manufacturing process, working with a network of contract manufacturing organizations (CMOs) and component suppliers. The company's positioning within the global pharmaceutical supply chain makes it a central figure in ensuring uninterrupted product availability.


Raw Material Suppliers

Nicotine Raw Materials

Critical to Nicorette production is pharmaceutical-grade nicotine, derived primarily from natural sources. The prevalent suppliers of pharmaceutical nicotine include:

  • Alkaloid AD (Bulgaria): A major producer of pharmaceutical-grade nicotine, Alkaloid supplies nicotine for various NRT products, including Nicorette. Their extraction and purification processes adhere to Good Manufacturing Practices (GMP), ensuring product safety and consistency [1].

  • Cedarcide Ltd. (United Kingdom): Specializes in nicotine procurement for pharmaceutical use, emphasizing sustainable sourcing and regulatory compliance. Cedarcide emphasizes tobacco plant extraction and chemical refinement.

  • Jiangsu Tobacco Corporation (China): Responsible for high-volume nicotine extraction from tobacco leaves, Jiangsu Tobacco has become a significant supplier amidst China's expanding pharmaceutical manufacturing sector.

Other Essential Components

Aside from nicotine, inert ingredients such as gum base, sweeteners, flavorings, and binders are sourced globally:

  • Gum Base Suppliers: Companies like Kuraray Co. Ltd. (Japan) and Eastman Chemical Company supply pharmaceutical-grade gum, chiefly polyvinyl acetate derivatives.

  • Flavoring Agents: Various flavor manufacturers, including Givaudan and Firmenich, provide mint-flavored components statically used in Nicorette Mint formulations.


Manufacturing Partners

In addition to Johnson & Johnson’s in-house facilities, a pivotal element of the supply chain involves CMOs that assist with large-scale manufacturing, packaging, and distribution.

  • Patheon (a Thermo Fisher Scientific company): Acts as a key CMO partner for J&J, particularly in production phases for NRT products, ensuring GMP compliance and scalable manufacturing capacity.

  • Vetter Pharma International GmbH: Specializes in packaging and final formulation stages for Nicorette, providing secondary packaging and labeling services.

  • Recipharm: Engaged in manufacturing and distributing Nicorette formulations, especially in markets where local manufacturing is necessary to meet regional regulations.


Distribution Networks

Effective distribution of Nicorette (Mint) products hinges on global logistics, including:

  • Wholesale Distributors: Companies like McKesson (USA), Alliance Healthcare (Europe), and Medipal Holdings (Japan) serve as primary channels, providing wide-reaching access to pharmacies and retail outlets.

  • Pharmaceutical Logistics Providers: Specialist logistics firms such as UPS Healthcare and DHL Life Sciences & Healthcare facilitate temperature-controlled shipping and rapid delivery across regions.

Regulatory and Market Entry Considerations

Suppliers must navigate complex regulatory environments. For example, ensuring nicotine purity standards aligned with European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), and Therapeutic Goods Administration (TGA) (Australia) requirements is critical. These regulations influence sourcing, manufacturing practices, and the approval process, thus impacting supplier selection and quality assurance protocols.


Emerging Trends in Supplier Dynamics

Recent shifts include increased sourcing from Southeast Asia, driven by cost efficiencies, and heightened emphasis on sustainable practices. Manufacturers increasingly seek suppliers with certified environmental management systems and corporate social responsibility credentials to meet evolving stakeholder expectations and regulatory standards.


Conclusion

Understanding the supplier landscape for Nicorette (Mint) reveals a complex global network that hinges on specialized raw materials, manufacturing expertise, and efficient distribution. Johnson & Johnson's strategic partnerships with pharmaceutical-grade nicotine providers, CMOs, and logistics firms underpin product availability and quality assurance. As the market for smoking cessation aids grows, supplier agility, regulatory compliance, and sustainable sourcing will remain pivotal in maintaining supply chain resilience.


Key Takeaways

  • Major player: Johnson & Johnson retains primary manufacturing and branding responsibilities, relying on a network of global suppliers and CMOs.

  • Raw material sourcing: Pharmaceutical-grade nicotine is primarily supplied by Alkaloid AD (Bulgaria), Jiangsu Tobacco (China), and Cedarcide Ltd. (UK). Ingredient quality directly impacts product efficacy and safety.

  • Manufacturing partners: CMOs such as Patheon and Recipharm facilitate large-scale production, ensuring GMP compliance and regional market access.

  • Distribution channels: Wide-reaching wholesale distributors and specialized logistics providers enable global product availability, requiring seamless coordination.

  • Regulatory influence: Suppliers must meet stringent international quality standards and adapt to regional regulatory frameworks, impacting sourcing and manufacturing decisions.


FAQs

  1. Who are the primary raw material suppliers for nicotine used in Nicorette?
    Alkaloid AD (Bulgaria), Jiangsu Tobacco Corporation (China), and Cedarcide Ltd. (UK) are the leading suppliers of pharmaceutical-grade nicotine used in Nicorette products.

  2. Does Johnson & Johnson outsource manufacturing for Nicorette?
    Yes. Johnson & Johnson partners with contract manufacturing organizations like Patheon and Recipharm to produce and package Nicorette formulations at scale.

  3. How does supply chain regulation impact Nicorette suppliers?
    Suppliers must adhere to strict GMP standards and regional regulatory requirements, such as those from the FDA and EMA, ensuring product safety and compliance.

  4. What are key considerations when sourcing ingredients for Mint-flavored Nicorette?
    Quality, purity, flavor stability, and regulatory compliance are critical factors in selecting suppliers for flavoring agents and excipients.

  5. Are there emerging suppliers or trends affecting Nicorette’s supply chain?
    Yes. There is a growing emphasis on sustainable sourcing, with suppliers in Southeast Asia gaining prominence, alongside increasing demand for environmentally compliant manufacturing processes.


References

[1] Bulgarian Pharmacopoeia. (2021). "Pharmaceutical Nicotine Production Standards." Bulgarian Pharmacopoeia Committee.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.